Trials / Completed
CompletedNCT06470334
Dexamethasone With Ropivacaine for PENG Block in Total Hip Arthroplasty
Pericapsular Nerve Group Block With 20 ml 0.2% Ropivacaine vs 10ml 0.2% Ropivacaine and Dexamethasone in Total Hip Arthroplasty: A Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Poznan University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 65 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
Does adding Dexamethasone to the Periarticular Nerve Group Block in Patients undergoing Total Hip Arthroplasty reduce the dose of ropivacaine?
Detailed description
Hip arthroplasty is one of the most common orthopaedic procedures, especially in elderly patients, due to the deformation of joints. Patients may complain of severe pain due to surgical trauma and prostheses. Regional anaesthesia methods may be performed to reduce the inflammatory response, opioid consumption, and opioid-related side effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ropivacaine | Ultrasound-guided PENG block - 20ml 0,2% ropivacaine |
| DRUG | Ropivacaine+Dexamethasone | Ultrasound-guided PENG block - 10ml 0,2% ropivacaine + 4mg Dexamethasone |
Timeline
- Start date
- 2024-11-07
- Primary completion
- 2025-03-31
- Completion
- 2025-04-30
- First posted
- 2024-06-24
- Last updated
- 2025-07-11
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT06470334. Inclusion in this directory is not an endorsement.